OTC: ACXIF 21.95%
Underperform Recommendation Issued On ACXIF By RBC Capital
NYSE: KORE 77.39%
KORE Reports Third Quarter 2025 Results
NASDAQ: ENSC 73.31%
Expected US Company Earnings on Tuesday, November 11th, 2025
NASDAQ: NGNE 31.15%
Neurogene Shares Rally on FDA Breakthrough Therapy Designation for Rett Syndrome Therapy
NASDAQ: BWIN 28.55%
Baldwin (BWIN) Q4 2025 Earnings Call Transcript
NYSE: DELL 21.57%
Why Dell Stock Surged Today
NYSE: ACXIF 77.39%
NYSE: ENSC 77.39%
NYSE: NGNE 77.39%
NYSE: BWIN 77.39%
